Menin-MLL inhibitor 31

O=C1C2(CCC2)NC([C@@]3([H])N(CCC3)C([C@@H](NC([C@H](CCCC[C@H](N1)C(N4C[C@@H](CC4)C(N[C@@H](CCCN)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@H](C(N)=O)CCCNC(N)=N)=O)=O)=O)=O)=O)NC([C@@H](NC([C@H](CCCNC(N)=N)NC([C@H](C)NC(C)=O)=O)=O)CC5=CNC6=CC=CC=C56)=O)=O)CC7=CC(F)=CC=C7)=O)=O

[1]Hao Lei, et al. Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia. J Med Chem. 2021 Nov 11;64 (21) :15519-15533.